COVID-19 Update: July 29, 2020

Dear Bearcat,  

COVID-19 continues to impact us in ways never imagined. As you prepare for the start of the Fall 2020 semester, we recognize the immense change and financial challenges that have developed as a result of this global pandemic.  

As a result, the university is reducing the General Fee and Campus Life Fee. Reduced rates for full-time students for the Fall 2020 semester are:  

  • General Fee:  $358.00 (10% reduction)  
  • Campus Life Fee: $218.45 (15% reduction) 

General and Campus Life fees support non-academic activities, some campus spaces and various recreational and entertainment facilities and programming. Other tuition and fees related to instruction, technology and most program fees will continue as these support ongoing teaching and academic advising, allowing students to earn and receive full academic credit toward graduation and degrees.

We hope these adjustments will assist you in continuing your future educational endeavors at UC. The university is here to support you during this unprecedented time and is working diligently each day to reduce potential impacts on you, your family, and our university community while continuing in our educational mission.

If you have any additional questions, please contact Campus One Stop:  

Telephone: 513-556-1000  

Email: onestop@uc.edu

Related Stories

1

Giddy: Here we go again: The return of the common cold

November 10, 2021

With people wearing masks over the past 18 months or so to ward off COVID-19, the incidence of the common cold has been reduced during that time. However, as more people get vaccines and boosters, and mask mandates are eased in some instances, the common cold could be poised to make a comeback as we head into the fall and winter months. Giddy posted a primer on what causes the common cold and how to combat it and one of the expert sources they cited was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

2

Health: Antidepressant for COVID-19 reduces hospitalization...

October 29, 2021

The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.

3

UC research examines coping mechanisms for loss of smell from...

October 21, 2021

One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from UC found some common coping mechanisms that helped COVID patients deal with a lessened sense of smell, which severely impacts the sense of taste. The study was published in the International Forum of Allergies and Rhinology. The combination of the loss of smell and taste, which are also known as the chemosensory senses, due to COVID-19 has been particularly devastating, with research showing associated depression, anxiety and impaired quality of life. It is something Katie Phillips, MD, assistant professor in the Department of Otolaryngology, Head & Neck Surgery at the UC College of Medicine sees in many COVID patients who come into her clinic.

Debug Query for this